What Supernus, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 10 |
| Sells | 0 | 3 |
| Total trades | 9 | 56 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 3,593,105 | 5,455,446 |
| Disposed | 0 | 870,072 |
| Net activity | +3,593,105 | +4,585,374 |
Common stock only — 5 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bhatt Padmanabh P. | SVP of IP, CSO | Nov 02 | Other Transaction · J | +28,702 | — | — | 28,702 |
| Rubin Jonathan | SVP, Chief Medical Officer | Nov 02 | Other Transaction · J | +21,529 | — | — | 21,529 |
| Gemayel Georges | Director | Nov 02 | Other Transaction · J | +42,009 | — | — | 42,009 |
| Dec Timothy C | SVP, Chief Financial Officer | Nov 02 | Other Transaction · J | +14,059 | — | — | 14,059 |
| Mottola Frank | SVP, Chief Tech. Ops. Officer | Nov 02 | Other Transaction · J | +30,099 | — | — | 30,099 |
| Khattar Jack A. | Chief Executive Officer | Nov 02 | Other Transaction · J | +1,475,569 | — | — | 1,475,569 |
| Khattar Jack A. | Chief Executive Officer | Nov 02 | Other Transaction · J | +1,937,986 | — | — | 1,937,986 |
| Barlow Carrolee | Director | Nov 02 | Other Transaction · J | +41,652 | — | — | 41,652 |
| Anderson Woodrow D | Chief Accounting Officer | Aug 27 | Open-market buy · P | +1,500 | $35.69 | +$53.5K | 27,638 |
| Anderson Woodrow D | Chief Accounting Officer | Aug 05 | Open-market buy · P | +1,500 | $36.28 | +$54.4K | 26,138 |
| Heidbreder Christian | Chief Scientific Officer | Jul 10 | Open-market sale · S | −18,586 | $41.14 | −$765K | 209,337 |
| Ciaffoni Joseph | Chief Executive Officer | Jun 22 | Withheld — tax / exercise cost · F | −612,549 | $38.32 | −$23.5M | 790,330 |
| Ciaffoni Joseph | Chief Executive Officer | Jun 22 | Exercise / conversion · M | +1,266,903 | — | — | 1,402,879 |
| Heidbreder Christian | Chief Scientific Officer | Jun 11 | Open-market sale · S | −18,586 | $38.06 | −$707K | 227,923 |
| Preblick Ryan | Chief Financial Officer | Jun 08 | Open-market sale · S | −36,000 | $37.70 | −$1.36M | 284,751 |
| Thompson Juliet | Director | May 13 | Grant / award · A | +6,518 | — | — | 12,973 |
| Wheadon David E. | Director | May 13 | Grant / award · A | +10,430 | — | — | 30,780 |
| Stejbach Mark | Director | May 13 | Grant / award · A | +6,518 | — | — | 27,087 |
| Ryan Barbara | Director | May 13 | Grant / award · A | +6,518 | — | — | 12,242 |
| Kingsley Stuart A | Director | May 13 | Grant / award · A | +6,518 | — | — | 12,100 |
Loading...